I love getting in on companies with low liquidity/tiny market cap, with this much promise before the bell goes.
La Paz results next week.
They already have a resource, low grade but an enormous amount of it, get the correct process in place for extracting what we already have, in an economical matter and boom, the sheer size of the resource will look after itself.
La Paz has strong government support locally (highly incentivised, will create hundreds of jobs) all the way to federally (lots of recent rhetoric around America being less reliant on China for these metals) There is a high likelihood of some government funding in future to really get the ball rolling in a mining friendly zone.
‘ARR was exempted from the Biden Administration’s 60-day moratorium on ground disturbing activities allowing it to start drilling at La Paz in March 2021.’
This, for a market cap of $27 million?? Now add the pending results to upgrade the size/grade of the existing resource (these results can only add onto what has already been proven). Where is the down side at this market cap? Throw in a lucrative scandium resource. The market is sleeping on the potential of the scandium.
Well funded for the foreseeable future.
Royalty stream from COB periodically in the $millions.
Broken hill tenements could sell for another $500k - $1000000 into the kitty.
Acquisition of Nevada project. Next door to MP minerals (market cap over $5 billion)
Wyoming acquisition to be finalised by the end of this month.
Acquisition of scandium mineral rights at the spilt rocks project, Western Australia (complimenting what they may deliver at La Paz)
All for $27 million? $27 million?? Today could well be the final day before the bell is rung.
- Forums
- ASX - By Stock
- Risk/Reward
I love getting in on companies with low liquidity/tiny market...
-
- There are more pages in this discussion • 28 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ARR (ASX) to my watchlist
(20min delay)
|
|||||
Last
28.5¢ |
Change
-0.005(1.72%) |
Mkt cap ! $143.0M |
Open | High | Low | Value | Volume |
29.0¢ | 29.5¢ | 28.5¢ | $234.5K | 816.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 36722 | 28.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
29.0¢ | 45112 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 9322 | 0.285 |
8 | 228157 | 0.280 |
4 | 11921 | 0.275 |
7 | 135083 | 0.270 |
4 | 125400 | 0.265 |
Price($) | Vol. | No. |
---|---|---|
0.290 | 73818 | 11 |
0.295 | 28917 | 3 |
0.300 | 91580 | 7 |
0.305 | 8100 | 1 |
0.310 | 54500 | 2 |
Last trade - 14.08pm 06/05/2024 (20 minute delay) ? |
|
|||||
Last
29.0¢ |
  |
Change
-0.005 ( 1.75 %) |
|||
Open | High | Low | Volume | ||
29.0¢ | 29.5¢ | 28.5¢ | 409092 | ||
Last updated 14.26pm 06/05/2024 ? |
Featured News
ARR (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, CEO
Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online